To verify the promotion effect of Pyk2 on glioma cell invasion after anti-VEGF treatment in vivo, tumor cell invasiveness surrounding the tumor rim in rat C6 intracranial xenograft was evaluated by vimentin staining [27] after bevacizumab treatment with or without Pyk2 inhibition. This evidence concerns the gene PTK2B and central nervous system cancer.